49 related articles for article (PubMed ID: 25388992)
21. Temporal bone carcinoma. Current diagnostic, therapeutic, and prognostic concepts.
Lionello M; Stritoni P; Facciolo MC; Staffieri A; Martini A; Mazzoni A; Zanoletti E; Marioni G
J Surg Oncol; 2014 Sep; 110(4):383-92. PubMed ID: 24962035
[TBL] [Abstract][Full Text] [Related]
22. Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models.
Zanoletti E; Marioni G; Stritoni P; Lionello M; Giacomelli L; Martini A; Mazzoni A
Laryngoscope; 2014 May; 124(5):1192-8. PubMed ID: 24108656
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma.
Marioni G; Nucci R; Marino F; Cappellesso R; Pillon M; Zanoletti E; Giacomelli L; Franchella S; Billo P; Pareschi R; Martini A
Otol Neurotol; 2013 Oct; 34(8):1476-82. PubMed ID: 24005169
[TBL] [Abstract][Full Text] [Related]
24. Role of relaxin-2 in human primary osteosarcoma.
Ma J; Niu M; Yang W; Zang L; Xi Y
Cancer Cell Int; 2013 Jun; 13(1):59. PubMed ID: 23758748
[TBL] [Abstract][Full Text] [Related]
25. Expression of the tumour-suppressor maspin in temporal bone carcinoma.
Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A
Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906
[TBL] [Abstract][Full Text] [Related]
26. Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.
Pan HZ; Dong AB; Wang L; Tan SS; Yang Q; Tong XY; Liang J; Wang JR
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1095-101. PubMed ID: 23661524
[TBL] [Abstract][Full Text] [Related]
27. Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.
Cernaro V; Lacquaniti A; Lupica R; Buemi A; Trimboli D; Giorgianni G; Bolignano D; Buemi M
Med Res Rev; 2014 Jan; 34(1):77-105. PubMed ID: 23401142
[TBL] [Abstract][Full Text] [Related]
28. Human relaxin-2: historical perspectives and role in cancer biology.
Nair VB; Samuel CS; Separovic F; Hossain MA; Wade JD
Amino Acids; 2012 Sep; 43(3):1131-40. PubMed ID: 22855207
[TBL] [Abstract][Full Text] [Related]
29. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105.
Marioni G; Nucci R; Marino F; Giacomelli L; Rugge M; Pareschi R; Martini A
Otol Neurotol; 2012 Jul; 33(5):843-8. PubMed ID: 22643443
[TBL] [Abstract][Full Text] [Related]
30. Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.
Bialek J; Kunanuvat U; Hombach-Klonisch S; Spens A; Stetefeld J; Sunley K; Lippert D; Wilkins JA; Hoang-Vu C; Klonisch T
Mol Cancer Res; 2011 Jun; 9(6):673-87. PubMed ID: 21493587
[TBL] [Abstract][Full Text] [Related]
31. Roles of epithelial-mesenchymal transition in squamous cell carcinoma of the temporal bone.
Sugimoto H; Ito M; Hatano M; Kondo S; Suzuki S; Yoshizaki T
Otol Neurotol; 2011 Apr; 32(3):483-7. PubMed ID: 21358455
[TBL] [Abstract][Full Text] [Related]
32. Relaxin stimulates osteoclast differentiation and activation.
Ferlin A; Pepe A; Facciolli A; Gianesello L; Foresta C
Bone; 2010 Feb; 46(2):504-13. PubMed ID: 19833242
[TBL] [Abstract][Full Text] [Related]
33. Role of relaxin in human osteoclastogenesis.
Facciolli A; Ferlin A; Gianesello L; Pepe A; Foresta C
Ann N Y Acad Sci; 2009 Apr; 1160():221-5. PubMed ID: 19416193
[TBL] [Abstract][Full Text] [Related]
34. Circulating levels of relaxin and its relation to cardiovascular function in patients with hypertension.
Gedikli O; Yilmaz H; Kiris A; Karaman K; Ozturk S; Baykan M; Ucar U; Durmus I; Karahan C; Celik S
Blood Press; 2009; 18(1-2):68-73. PubMed ID: 19353414
[TBL] [Abstract][Full Text] [Related]
35. Relaxin promotes prostate cancer progression.
Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
[TBL] [Abstract][Full Text] [Related]
36. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 95 cases of squamous cell carcinoma of the external and middle ear.
Yin M; Ishikawa K; Honda K; Arakawa T; Harabuchi Y; Nagabashi T; Fukuda S; Taira A; Himi T; Nakamura N; Tanaka K; Ichinohe M; Shinkawa H; Nakada Y; Sato H; Shiga K; Kobayashi T; Watanabe T; Aoyagi M; Ogawa H; Omori K
Auris Nasus Larynx; 2006 Sep; 33(3):251-7. PubMed ID: 16431060
[TBL] [Abstract][Full Text] [Related]
38. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients.
Binder C; Simon A; Binder L; Hagemann T; Schulz M; Emons G; Trümper L; Einspanier A
Breast Cancer Res Treat; 2004 Sep; 87(2):157-66. PubMed ID: 15377840
[TBL] [Abstract][Full Text] [Related]
39. Staging system revision.
Hirsch BE
Arch Otolaryngol Head Neck Surg; 2002 Jan; 128(1):93-4. PubMed ID: 11784271
[No Abstract] [Full Text] [Related]
40. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system.
Moody SA; Hirsch BE; Myers EN
Am J Otol; 2000 Jul; 21(4):582-8. PubMed ID: 10912706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
